The bill amends the North Dakota Century Code to update the scheduling of controlled substances, particularly focusing on Schedule I, III, and the definitions of anabolic steroids and hallucinogenic substances. It introduces several new substances, including various opiates, fentanyl derivatives, synthetic cannabinoids, and new stimulant compounds such as ethylphenidate and derivatives of cathinone. Notable insertions include specific chemical names and structural descriptions for these substances, which aim to enhance regulatory measures against the proliferation of synthetic drugs and address public health concerns. The bill also clarifies definitions and classifications to ensure appropriate regulation under state law.

In addition to the new insertions, the bill removes certain compounds from the controlled substances list, including specific names that are no longer deemed necessary for regulation. It also refines the language regarding anabolic steroids by removing the term "anabolic" and specifying that the substances include their salts, esters, and ethers. Furthermore, it introduces a new category for hallucinogenic substances, recognizing the FDA-approved crystalline polymorph psilocybin, known as COMP360. The bill allows the board to exempt certain compounds containing depressant substances if they do not affect the central nervous system, ensuring that legitimate medicinal uses are not hindered. The declaration of an emergency underscores the urgency of these changes to combat substance abuse effectively.

Statutes affected:
PREFILED: 19-03.1-05, 19-03.1-09, 19-03.1-11
Adopted by the House Human Services Committee: 19-03.1-05, 19-03.1-09, 19-03.1-11
Enrollment: 19-03.1-05, 19-03.1-09, 19-03.1-11
INTRODUCED: 19-03.1-05, 19-03.1-09, 19-03.1-11